TATVA CHINTAN PHARMA CHEM
|
TATVA CHINTAN PHARMA CHEM Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 12.98 | 20.52 | 43.25 | 26.02 | 47.03 |
| CEPS(Rs) | 23.92 | 24.83 | 46.95 | 29.37 | 21.20 |
| DPS(Rs) | 2.00 | 2.00 | 2.00 | 5.00 | - |
| Book NAV/Share(Rs) | 315.10 | 232.25 | 213.44 | 82.62 | 146.48 |
| Tax Rate(%) | 30.33 | -1.58 | 7.92 | 13.90 | 20.61 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 17.33 | 14.34 | 25.01 | 22.17 | 21.00 |
| EBIT Margin(%) | 12.75 | 12.60 | 25.20 | 21.66 | 19.70 |
| Pre Tax Margin(%) | 11.04 | 10.57 | 24.00 | 20.18 | 18.08 |
| PAT Margin (%) | 7.69 | 10.73 | 22.10 | 17.38 | 14.36 |
| Cash Profit Margin (%) | 14.18 | 12.99 | 23.98 | 19.62 | 16.18 |
| Performance Ratios | |||||
| ROA(%) | 3.90 | 6.53 | 19.68 | 18.21 | 17.32 |
| ROE(%) | 4.85 | 9.21 | 30.01 | 36.85 | 38.29 |
| ROCE(%) | 7.00 | 8.35 | 25.75 | 28.04 | 28.40 |
| Asset Turnover(x) | 0.51 | 0.61 | 0.89 | 1.05 | 1.21 |
| Sales/Fixed Asset(x) | 1.10 | 2.03 | 2.67 | 2.30 | 2.69 |
| Working Capital/Sales(x) | 1.81 | 5.76 | 1.64 | 4.54 | 5.84 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.91 | 0.49 | 0.37 | 0.43 | 0.37 |
| Receivable days | 71.34 | 60.72 | 61.98 | 85.15 | 62.97 |
| Inventory Days | 145.79 | 143.16 | 101.78 | 82.27 | 68.74 |
| Payable days | 80.91 | 61.91 | 86.25 | 94.96 | 73.88 |
| Valuation Parameters | |||||
| PER(x) | 83.19 | 81.23 | 53.35 | - | - |
| PCE(x) | 45.13 | 67.12 | 49.16 | - | - |
| Price/Book(x) | 3.43 | 7.18 | 10.81 | - | - |
| Yield(%) | 0.19 | 0.12 | 0.09 | - | - |
| EV/Net Sales(x) | 6.36 | 9.02 | 11.66 | 0.35 | 0.33 |
| EV/Core EBITDA(x) | 32.95 | 57.43 | 43.03 | 1.46 | 1.55 |
| EV/EBIT(x) | 49.73 | 71.57 | 46.25 | 1.61 | 1.69 |
| EV/CE(x) | 3.33 | 5.58 | 8.53 | 0.41 | 0.42 |
| M Cap / Sales | 6.42 | 8.72 | 11.80 | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | -7.11 | -2.31 | 44.38 | 14.10 | 27.60 |
| Core EBITDA Growth(%) | 14.10 | -43.40 | 63.52 | 26.86 | 63.71 |
| EBIT Growth(%) | -5.77 | -51.19 | 67.87 | 25.60 | 65.49 |
| PAT Growth(%) | -33.27 | -52.56 | 83.45 | 38.30 | 83.95 |
| EPS Growth(%) | -36.77 | -52.56 | 66.26 | -44.68 | 83.95 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.33 | 0.25 | 0.54 | 0.77 |
| Current Ratio(x) | 3.51 | 1.31 | 2.54 | 1.52 | 1.51 |
| Quick Ratio(x) | 1.75 | 0.63 | 1.55 | 0.95 | 0.79 |
| Interest Cover(x) | 7.47 | 6.21 | 20.90 | 14.65 | 12.15 |
| Total Debt/Mcap(x) | 0.01 | 0.05 | 0.02 | - | - |
Compare Financial Ratios of peers of TATVA CHINTAN PHARMA CHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TATVA CHINTAN PHARMA CHEM | ₹1,925.8 Cr | -1.2% | -11.9% | -46.3% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹150,478.0 Cr | -2.1% | -5.4% | 17% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹90,766.5 Cr | 0.4% | -7.2% | 34.8% | Stock Analytics | |
| SRF | ₹64,201.2 Cr | -3.1% | -0.5% | -9.3% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹41,885.3 Cr | -7% | -19.1% | 36.3% | Stock Analytics | |
| DEEPAK NITRITE | ₹36,422.4 Cr | 1.3% | 0.8% | 22.1% | Stock Analytics | |
TATVA CHINTAN PHARMA CHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TATVA CHINTAN PHARMA CHEM | -1.2% |
-11.9% |
-46.3% |
| SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses
